Cargando…

Randomised clinical trial and meta‐analysis: mesalazine treatment in irritable bowel syndrome—effects on gastrointestinal symptoms and rectal biomarkers of immune activity

BACKGROUND: Low‐grade immune activation in the gut is a potential treatment target in irritable bowel syndrome (IBS). AIMS: To determine improvement in IBS symptoms after mesalazine treatment, and the utility of measures of immune activity in the rectal mucosa METHODS: This was a randomised, double‐...

Descripción completa

Detalles Bibliográficos
Autores principales:	Castro Tejera, Valeria, Öhman, Lena, Aabakken, Lars, Fellström, Bengt, Hausken, Trygve, Hovde, Øistein, Hreinsson, Johann P., Lindberg, Greger, Venge, Per, Simrén, Magnus, Törnblom, Hans
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Mesalazine in IBS
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543538/ https://www.ncbi.nlm.nih.gov/pubmed/35942522 http://dx.doi.org/10.1111/apt.17182

Ejemplares similares

Direct healthcare costs of Rome IV or Rome III‐defined irritable bowel syndrome in the United Kingdom
por: Goodoory, Vivek C., et al.
Publicado: (2022)

Irritable bowel syndrome: Factors of importance for disease‐specific quality of life
por: Melchior, Chloé, et al.
Publicado: (2022)

Willingness to accept risk with medication in return for cure of symptoms among patients with Rome IV irritable bowel syndrome
por: Goodoory, Vivek C., et al.
Publicado: (2022)

Type of Rectal Barostat Protocol Affects Classification of Hypersensitivity and Prediction of Symptom Severity in Irritable Bowel Syndrome
por: Josefsson, Axel, et al.
Publicado: (2022)

Associations between postprandial symptoms, hydrogen and methane production, and transit time in irritable bowel syndrome
por: Algera, Joost P., et al.
Publicado: (2022)

Health care utilization of individuals with Rome IV irritable bowel syndrome in the general population
por: Tornkvist, Navkiran T., et al.
Publicado: (2021)

Impact of Rome IV irritable bowel syndrome on work and activities of daily living
por: Goodoory, Vivek C., et al.
Publicado: (2022)

Abnormalities of mucosal serotonin metabolism and 5‐HT(3) receptor subunit 3C polymorphism in irritable bowel syndrome with diarrhoea predict responsiveness to ondansetron
por: Gunn, David, et al.
Publicado: (2019)

Randomised controlled trial: effects of gluten‐free diet on symptoms and the gut microenvironment in irritable bowel syndrome
por: Algera, Joost P., et al.
Publicado: (2022)

Randomised clinical trial: individual versus group hypnotherapy for irritable bowel syndrome
por: Lövdahl, Jenny, et al.
Publicado: (2022)

Irritable bowel syndrome with food‐related symptoms: Future directions in the clinical management
por: Melchior, Chloé, et al.
Publicado: (2022)

The Role of Carbohydrates in Irritable Bowel Syndrome: Protocol for a Randomized Controlled Trial Comparing Three Different Treatment Options
por: Nybacka, Sanna, et al.
Publicado: (2022)

Diet and gut microbiome interactions of relevance for symptoms in irritable bowel syndrome
por: Tap, Julien, et al.
Publicado: (2021)

Maintaining work life under threat of symptoms: a grounded theory study of work life experiences in persons with Irritable Bowel Syndrome
por: Frändemark, Åsa, et al.
Publicado: (2022)

Fecal luminal factors from patients with irritable bowel syndrome induce distinct gene expression of colonoids
por: Iribarren, Cristina, et al.
Publicado: (2022)

Predictors of Symptom-Specific Treatment Response to Dietary Interventions in Irritable Bowel Syndrome
por: Colomier, Esther, et al.
Publicado: (2022)

Gut Microbiota as Potential Orchestrators of Irritable Bowel Syndrome
por: Bennet, Sean M.P., et al.
Publicado: (2015)

Associations among neurophysiology measures in irritable bowel syndrome (IBS) and their relevance for IBS symptoms
por: Midenfjord, Irina, et al.
Publicado: (2020)

A novel stepwise integrative analysis pipeline reveals distinct microbiota-host interactions and link to symptoms in irritable bowel syndrome
por: Polster, Annikka, et al.
Publicado: (2021)

Habitual FODMAP Intake in Relation to Symptom Severity and Pattern in Patients with Irritable Bowel Syndrome
por: Nybacka, Sanna, et al.
Publicado: (2020)

A Distinct Faecal Microbiota and Metabolite Profile Linked to Bowel Habits in Patients with Irritable Bowel Syndrome
por: Ahluwalia, Bani, et al.
Publicado: (2021)

Systemic Inflammatory Protein Profiles Distinguish Irritable Bowel Syndrome (IBS) and Ulcerative Colitis, Irrespective of Inflammation or IBS-Like Symptoms
por: Moraes, Luiza, et al.
Publicado: (2020)

Changes in serum and urinary metabolomic profile after a dietary intervention in patients with irritable bowel syndrome
por: Nybacka, Sanna, et al.
Publicado: (2021)

Clinical, endoscopical and morphological efficacy of mesalazine in patients with irritable bowel syndrome
por: Dorofeyev, Andrey E, et al.
Publicado: (2011)

Effectiveness of mesalazine to treat irritable bowel syndrome: A meta-analysis
por: Zhang, Fen-Ming, et al.
Publicado: (2019)

Chlamydia trachomatis antigens in enteroendocrine cells and macrophages of the small bowel in patients with severe irritable bowel syndrome
por: Dlugosz, Aldona, et al.
Publicado: (2010)

Fasting breath H(2) and gut microbiota metabolic potential are associated with the response to a fermented milk product in irritable bowel syndrome
por: Le Nevé, Boris, et al.
Publicado: (2019)

Association between Brachyspira and irritable bowel syndrome with diarrhoea
por: Jabbar, Karolina S, et al.
Publicado: (2021)

Evidence of altered mucosa-associated and fecal microbiota composition in patients with Irritable Bowel Syndrome
por: Sundin, Johanna, et al.
Publicado: (2020)

Within- and Between-Subject Variation in Dietary Intake of Fermentable Oligo-, Di-, Monosaccharides, and Polyols Among Patients with Irritable Bowel Syndrome
por: Nybacka, Sanna, et al.
Publicado: (2018)

Irritable Bowel Syndrome
por: Farup, Per G., et al.
Publicado: (2012)

Association between pain sensitivity and gray matter properties in the sensorimotor network in women with irritable bowel syndrome
por: Grinsvall, Cecilia, et al.
Publicado: (2020)

Chromogranin A cells in the stomachs of patients with sporadic irritable bowel syndrome
por: EL-SALHY, MAGDY, et al.
Publicado: (2014)

The Effects of Human Milk Oligosaccharides on Gut Microbiota, Metabolite Profiles and Host Mucosal Response in Patients with Irritable Bowel Syndrome
por: Iribarren, Cristina, et al.
Publicado: (2021)

Altered Structural Covariance of Insula, Cerebellum and Prefrontal Cortex Is Associated with Somatic Symptom Levels in Irritable Bowel Syndrome (IBS)
por: Grinsvall, Cecilia, et al.
Publicado: (2021)

Diet in Irritable Bowel Syndrome (IBS): Interaction with Gut Microbiota and Gut Hormones
por: El-Salhy, Magdy, et al.
Publicado: (2019)

Global prevalence and burden of meal-related abdominal pain
por: Colomier, Esther, et al.
Publicado: (2022)

Evidence for an association of gut microbial Clostridia with brain functional connectivity and gastrointestinal sensorimotor function in patients with irritable bowel syndrome, based on tripartite network analysis
por: Labus, Jennifer S., et al.
Publicado: (2019)

Density of Musashi-1-positive stem cells in the stomach of patients with irritable bowel syndrome
por: El-Salhy, Magdy, et al.
Publicado: (2020)

Work productivity and activity impairment in disorders of gut‐brain interaction: Data from the Rome Foundation Global Epidemiology Study
por: Frändemark, Åsa, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_18hie9j37fpq7rtkvpfiee9qs9